After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Resmed Inc is listed on the NYSE in the Healthcare sector while operating in the Medical Instruments & Supplies industry. The current market capitalization of Resmed Inc is $39.68B. A total of 1.03 million shares were traded on the day, compared to an average of 932.78K shares.
In the most recent transaction, Sandercock Brett bought 3,000 shares of RMD for 270.77 per share on Sep 02 ’25. In a previous transaction on Aug 18 ’25, Hernandez John sold 2,575 shares at 287.10 per share. RMD shares that Director owns now total 4,045.
Among the insiders who bought shares, Hernandez John acquired of 2,575 shares on Aug 18 ’25 at a per-share price of $287.10. In another insider transaction, Farrell Michael J. sold 8,009 shares at $279.48 per share on Aug 07 ’25. Company shares held by the Chief Executive Officer now total 455,503.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Resmed Inc pays an annual dividend of $2.19, resulting in a dividend yield of 0.81%, and it has a price to earnings (P/E) ratio of 28.50.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RMD has a high of $293.81 and a low of $199.92.
As of this writing, RMD has an earnings estimate of $2.5 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $2.56 per share and a lower estimate of $2.45. The company reported an EPS of $2.2 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RMD’s latest balance sheet shows that the firm has $273.71M in Cash & Short Term Investments as of fiscal 2022. There were $917.55M in debt and $689.30M in liabilities at the time. Its Book Value Per Share was $40.77, while its Total Shareholder’s Equity was $3.36B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RMD is Buy with a score of 4.00.